https://www.selleckchem.com/pr....oducts/eribulin-mesy
029; 3 h 92% 74%, P=0.016), although the mean mitigation rate (81% 85%, P=0.80 was comparable between the two groups. NIV failure, defined as reintubation or death over the course of study, was comparable between the two groups (19.2% 21.1%, respectively, P=0.831). There were no significant differences between the two groups in other clinical outcomes, including tracheostomy (15.4% 15.8%, P=0.958), in-hospital mortality (11.5% 10.5%, P=0.88, ICU length of stay (LOS) (7 7 days, P=0.802), and in-hospital LOS (17 19 day
Like
Comment
Share
